-+ 0.00%
-+ 0.00%
-+ 0.00%

Addex Therapeutics files Form 3 initial beneficial ownership statement; Director Vincent Michael Lawton reports 2.5 million common shares

Reuters·03/25/2026 20:03:54

Please log in to view news